Literature DB >> 4976111

The effect of anti-lymphocyte globulin on cell-mediated reistance to infection.

G B Mackaness, W C Hill.   

Abstract

The specificity of anti-lymphocyte globulin (ALG) has been used to analyze an immune mechanism which is mediated by immunologically committed lymphoid cells to the apparent exclusion of humoral antibody. Rabbit antimouse lymphocyte globulin completely suppressed the immunity which can be passively transferred with Listeria-immune lymphoid cells from actively infected donors. When prospective donors were given a single dose of 1.0 mg of ALG, it remained active against immune lymphoid cells transferred 24 hr later; yet immune cells in the spleens of donors could not be inactivated in situ by even larger doses of ALG given 24 hr prior to cell harvest. In keeping with this finding, the immunity to reinfection with Listeria was not suppressed by a single dose of ALG, indicating that the immunologically active cells in the spleen are not accessible to intravenously administered ALG. On the other hand, protracted treatment with ALG did abolish most of the memory of a previous infection in intact animals. From this and other evidence, it was concluded that immunologically committed cells are vulnerable to attack by ALG only if they circulate. While in circulation, they make contact both with ALG and the phagocytic elements of the reticuloendothelial system which appear to be responsible for their destruction. Four lines of evidence indicated that the suppression of anti-Listeria resistance with ALG depends upon destruction of immune lymphoid cells and not to any action it has on host macrophages. It is possible to infer from this that immunity to L. monocytogenes depends upon a two cell system in which the donor lymphoid cells provide the immunological reactivity to the organism and recipient macrophages provide the mechanism through which resistance is expressed. Accompanying papers provide additional support for this view, and reasons for believing that delayed-type hypersensitivity and acquired cellular resistance are mediated by the same population of immunologically committed lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4976111      PMCID: PMC2138648          DOI: 10.1084/jem.129.5.993

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  The output of lymphocytes from the thoracic duct of unanaesthetized mice.

Authors:  B M GESNER; J L GOWANS
Journal:  Br J Exp Pathol       Date:  1962-08

2.  Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice.

Authors:  A M Denman; E P Frenkel
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

3.  Enhancing effect of antilymphocytic serum on mycobacterial infections in mice.

Authors:  J Gaugas; R J Rees
Journal:  Nature       Date:  1968-07-27       Impact factor: 49.962

Review 4.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

5.  Differential effect of heterologous anti-lymphocyte serum on antibody-producing cells and antigen-sensitive cells.

Authors:  G Möller; C Zukoski
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

6.  Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin.

Authors:  W J Martin; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

7.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

8.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

9.  The carriage of immunological memory by small lymphocytes in the rat.

Authors:  J L Gowans; J W Uhr
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

10.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

View more
  36 in total

Review 1.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

2.  Immunosuppressive agents in intracellular infection: besnoitiosis in hamsters.

Authors:  H R Wilson; J K Frenkel
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

Review 3.  Epidemiology of human listeriosis.

Authors:  A Schuchat; B Swaminathan; C V Broome
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Suppressor T cells and host resistance to tye 111 pneumococcus after treatment with antilymphocyte serum.

Authors:  R F Barth; O Singla; C Liu
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

Review 5.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

6.  Enhanced primary resistance to Listeria monocytogenes in T cell-deprived mice.

Authors:  C Chan; P A Kongshavn; E Skamene
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

7.  Effects of antithymocyte and antimacrophage sera on the survival of mice infected with Listeria monocytogenes.

Authors:  L D Pearson; J W Osebold
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

8.  Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread.

Authors:  R A Barry; H G Bouwer; D A Portnoy; D J Hinrichs
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Effect of tilorone on susceptibility of mice to primary or secondary infection with Listeria monocytogenes.

Authors:  R Gruenewald; S Levine
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

10.  Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.

Authors:  A B Onderdonk; R B Markham; D F Zaleznik; R L Cisneros; D L Kasper
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.